[Attitude towards heparine-induced thrombocytopenia].
Solari
Paula
P
Servicio de Farmacología Clínica, Fundació Institut Català de Farmacologia, Hospital Vall d'Hebron, Barcelona, España.
Bosch
Montserrat
M
D000925:Anticoagulants / Q000009:adverse effects*; D000990:Antithrombin III / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D013917:Thrombin / Q000037:antagonists & inhibitors*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy*
D000925:Anticoagulants; D000990:Antithrombin III; D006493:Heparin; D013917:Thrombin